Relationship between health-related quality of life and objective cough frequency in a phase 2b trial of gefapixant
S. Birring (London, United Kingdom), D. Muccino (Kenilworth, United States of America), E. Bacci (Bethesda, United States of America), M. Vernon (Bethesda, United States of America), J. Schelfhout (Kenilworth, United States of America), A. Nguyen (Kenilworth, United States of America)
Source: International Congress 2019 – Highlights in lung function and chronic cough
Session: Highlights in lung function and chronic cough
Session type: Poster Discussion
Number: 614
Disease area: Airway diseases
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Birring (London, United Kingdom), D. Muccino (Kenilworth, United States of America), E. Bacci (Bethesda, United States of America), M. Vernon (Bethesda, United States of America), J. Schelfhout (Kenilworth, United States of America), A. Nguyen (Kenilworth, United States of America). Relationship between health-related quality of life and objective cough frequency in a phase 2b trial of gefapixant. 614
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you: